Abstract
BackgroundTofacitinib is a novel, oral Janus kinase inhibitor for the treatment of rheumatoid arthritis (RA).ObjectivesTo evaluate the malignancies that occurred in Japanese patients in the tofacitinib RA programme from the...
Talk to us
Join us for a 30 min session where you can share your feedback and ask us any queries you have